Showing results (31-40 of 1,105) with videos related to
Sort By:
Pageof 111
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 14, 2011
Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort studySeo Young Kim, Sebastian Schneeweiss, Jun Liu, et al.Annals of the Rheumatic Diseases|June 30, 2010
Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasisDaniel H Solomon, Thorvardur Jon Love, Claire Canning, et al.Arthritis Care & Research|May 14, 2013
Risk of venous thromboembolism in patients with rheumatoid arthritisSeoyoung C Kim, Sebastian Schneeweiss, Jun Liu, et al.Journal of Clinical Epidemiology|January 15, 2005
A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitorsSebastian Schneeweiss, Robert J Glynn, Jerry Avorn, et al.Pharmacoepidemiology and Drug Safety|June 1, 2011
Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic "matrix design"Jeremy A Rassen, Daniel H Solomon, Robert J Glynn, et al.Epidemiology (Cambridge, Mass.)|April 18, 2006
Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variableM Alan Brookhart, Philip S Wang, Daniel H Solomon, et al.Journal of Clinical Epidemiology|March 10, 2007
Veteran's affairs hospital discharge databases coded serious bacterial infections accuratelySebastian Schneeweiss, Ari Robicsek, Richard Scranton, et al.Plos One|July 5, 2023
Body mass index and all-cause mortality in a 21st century U.S. population: A National Health Interview Survey analysisAayush Visaria, Soko SetoguchiThe American Journal of Medicine|December 25, 2003
Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?Daniel H Solomon, Sebastian Schneeweiss, Robert J Glynn, et al.Medical Care|June 27, 2006
Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy reviewMichael A Fischer, Hailu Cheng, Sebastian Schneeweiss, et al.Pageof 111